About
Technology
Issues
FAQ
Links
Official Page
Gefitinib for oesophageal cancer progressing after chemotherapy (COG): a phase 3, multicentre, double-blind, placebo-controlled randomised trial
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.